Kuznicki Law is investigating the proposed sale of Olink Holding AB (publ) (NasdaqGS: OLK) to Thermo Fisher Scientific Inc. (NYSE: TMO). Under the terms of the proposed transaction, shareholders of Olink will receive $26.00 in cash for each common share of Olink that they own. Kuznicki Law is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
Please note that the merger is structured as a tender offer, such that time may be of the essence.